Nanoleq GmbH

Based in Switzerland, Nanoleq AG operates as a pioneering company focused on developing smart textile solutions that enhance health monitoring and wellness through advanced technology integration. Nanoleq GmbH, founded in 2017 in Zurich, Switzerland, specializes in innovative smart textiles. The company has successfully completed 3 funding deals, with the most recent one being a Series A round amounting to CHF 11. 500 mn led by Capnamic on November 15, 2024.

The founders, Flurin Stauffer, Serge Weydert, and Vincent Martinez, bring a wealth of experience to the company, with Vincent Martinez currently serving as CEO. Nanoleq specializes in the development of innovative smart textile solutions that integrate advanced monitoring capabilities for health and wellness. Its core offerings include ElectroSkin electrodes, which facilitate the tracking of electromyography (EMG), electrocardiogram (ECG), and electroencephalography (EEG) signals, as well as providing electrical muscle stimulation (EMS) and functional electrical stimulation (FES). These products are designed to enhance athletic performance, support medical monitoring, and improve overall well-being.

The technology enables real-time health monitoring for various end users, including athletes, medical professionals, and individuals seeking to manage their health independently. Nanoleq's products have found applications across multiple sectors, including medical wear, sportswear, and workwear, with a customer base that spans Europe, North America, and Asia. The revenue generation model of Nanoleq is primarily structured around partnerships and B2B transactions, where the company collaborates with medical institutions, sports organizations, and wearable technology manufacturers. Transactions typically occur through direct contracts with clients who integrate Nanoleq’s smart textile components into their products or services.

Given the specialized nature of the technology, pricing reflects the high value of flagship products such as the ECG shirt and the Heart Monitoring Bundle. These products cater to a niche market that necessitates reliable performance and durability, further solidifying their position in the smart textiles industry. The company's revenue streams are diversified through these partnerships and direct sales, ensuring stability and growth in various geographical markets. In November 2024, Myant Inc.

acquired Nanoleq AG from Capnamic, Verve Ventures, and Zürcher Kantonalbank for an undisclosed amount. This acquisition enables Myant Inc. to enhance its medical devices portfolio by integrating Nanoleq's advanced sensor capabilities. The strategic integration is expected to broaden the scope of services offered to clients, leveraging Nanoleq's innovative technology.